
New product
4 x 2.4mg units
Warning: Last items in stock!
Availability date:
No reward points for this product because there's already a discount.
Wegovy® contains semaglutide, a once-weekly GLP-1 receptor agonist approved for chronic weight management in adults with obesity or overweight (with a weight-related condition). It’s also approved to reduce the risk of major cardiovascular events in certain adults with established CVD and obesity/overweight. By mimicking the body’s GLP-1 hormone, Wegovy helps regulate appetite, fullness, and insulin responses, supporting meaningful weight loss under medical supervision.
Wegovy supports both weight loss and metabolic control through three well-characterized actions:
Enhances glucose-dependent insulin secretion → better post-meal control
Suppresses glucagon → less hepatic glucose output
Slows gastric emptying & increases satiety → reduced hunger and lower caloric intake
Clinically significant weight loss when combined with diet and activity guidance
Improved glycemic measures and cardiometabolic markers in eligible patients
Cardiovascular risk reduction indication in adults with CVD and obesity/overweight
Simple weekly dosing with a single-use, prefilled pen
Results vary by individual. Use only as prescribed and alongside a reduced-calorie meal plan and increased physical activity.
Dosing schedule: Wegovy is titrated to reduce GI side effects: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg, typically increasing every 4 weeks until the 2.4 mg maintenance dose.
1-month supply: once at maintenance, a monthly fill generally includes 4 single-dose 2.4 mg pens (one injection per week).
Administration: subcutaneous injection into the abdomen, thigh, or upper arm; rotate sites.
Storage: follow pen instructions for refrigeration/room-temperature windows and disposal.
Always follow your prescriber’s plan; do not change doses without medical advice.
Your clinician may prescribe Wegovy alone or with other therapies. If used with insulin or sulfonylureas, your provider may adjust those doses to minimize hypoglycemia risk. Discuss all medications and supplements with your prescriber.
Common effects: nausea, vomiting, diarrhea/constipation, abdominal pain, decreased appetite, headache, fatigue. These often lessen after dose escalation.
Serious risks (seek medical care): signs of pancreatitis, gallbladder problems, allergic reactions, worsening diabetic retinopathy, acute kidney issues, or persistent severe GI symptoms.
Do not use if you have a personal/family history of medullary thyroid carcinoma (MTC), MEN2, or prior serious reaction to semaglutide. Not for pregnancy. Your prescriber will review warnings, monitoring, and whether Wegovy is appropriate for you.
We support authentic, pharmacy-dispensed Wegovy with:
Prescription verification and clinician-guided dosing
Transparent pricing on the 2.4 mg (1-month) maintenance supply
Fast, discreet domestic delivery
Knowledgeable support for ordering, refills, and device questions
If you’re searching for “Wegovy near me,” “buy Wegovy 2.4 mg online,” or “semaglutide weight loss near me,” our team helps streamline the process—always with a valid prescription.
Rx-grade authenticity: sourced through licensed channels
Precise, up-to-date guidance: titration and storage instructions included with every order
Customer care 24/7: real support before and after purchase
Comparing options? Visit our Semaglutide vs. Tirzepatide guide to review mechanisms (GLP-1 vs. dual incretin), dosing, and typical use cases—then consult your clinician to choose the best fit.
Have questions about Wegovy 2.4 mg availability, pricing, or refills? Contact us for assistance. If you’re new to therapy, we can help coordinate next steps with a licensed provider so you can see if Wegovy is right for you.